Kenneth Keiler

Professor of Biochemistry and Molecular Biology

Kenneth Keiler

Research Summary

Small RNAs and protein localization in bacterial development and antimicrobial drug discovery.

Huck Affiliations

Links

Publication Tags

These publication tags are generated from the output of this researcher. Click any tag below to view other Huck researchers working on the same topic.

Ribosomes Bacteria Anti Bacterial Agents Proteins Protein Peptides Messenger Rna Antimicrobial Agent Mycobacterium Tuberculosis Membranes Hyaluronic Acid Cells Mitochondria Transfer Rna Peptide Proteomics Pathogens Genes Data Analysis Molecule Pharmaceutical Preparations Membrane Proteins Polysaccharides Antibiotics Growth

Most Recent Publications

Neeraja Marathe, Ha An Nguyen, John N. Alumasa, Alexandra B. Kuzmishin Nagy, Michael Vazquez, Christine M. Dunham, Kenneth C. Keiler, 2023, mBio

Melissa Vázquez-Hernández, Stephanie L. Leedom, Kenneth C. Keiler, Julia Elisabeth Bandow, 2023, Proteomics

Kenneth Keiler, 2023,

Gonorrhea became more drug resistant while attention was on COVID-19 – a molecular biologist explains the sexually transmitted superbug

Kenneth Keiler, 2022, The Conversation

Stephanie L. Leedom, Kenneth C. Keiler, 2022, Current Biology on p. R469-R472

Z Aron, A Mehrani, E Hoffer, K Connolly, P Srinivas, M Torhan, John Alumasa, Mynthia Cabrera Goss, D Hosangadi, J Barbor, S Cardinale, S Kwasny, L Morin, M Butler, T Opperman, T Bowlin, A Jerse, S Stagg, C Dunham, Kenneth Keiler, 2021, Nature Communications on p. 1799

Christoph H.R. Senges, Jennifer J. Stepanek, Michaela Wenzel, Nadja Raatschen, Ümran Ay, Yvonne Märtens, Pascal Prochnow, Melissa Vázquez Hernández, Abdulkadir Yayci, Britta Schubert, Niklas B.M. Janzing, Helen L. Warmuth, Martin Kozik, Jens Bongard, John N. Alumasa, Bauke Albada, Maya Penkova, Tadeja Lukežič, Nohemy A. Sorto, Nicole Lorenz, Reece G. Miller, Bingyao Zhu, Martin Benda, Jörg Stülke, Sina Schäkermann, Lars I. Leichert, Kathi Scheinpflug, Heike Brötz-Oesterhelt, Christian Hertweck, Jared T. Shaw, Hrvoje Petković, Jean M. Brunel, Kenneth C. Keiler, Nils Metzler-Nolte, Julia E. Bandow, 2021, Antimicrobial Agents and Chemotherapy

D Larivière, L Wickham, Kenneth Keiler, Anton Nekrutenko, 2021, BMC Microbiology on p. 1--15

Andrew Simonson^, Andrew W. Simonson, A Mongia, Agustey Mongia^, Matthew R. Aronson, Agustey S. Mongia, M Aronson, Matthew Aronson^, John N. Alumasa, Dennis Chan, Adam Bolotsky, Atip Lawanprasert^, A Lawanprasert, Michael Howe, Aida Ebrahimi, Elizabeth Proctor, Adam Bolotsky, T. Mal, Kenneth C. Keiler, Scott H. Medina, Christy George, S Ebrahimi, A Ebrahimi, A Baughn, Elizabeth Proctor, Kenneth Keiler, Scott Medina*, S Medina, 2020, Nature Biomedical Engineering on p. 467-480

Most-Cited Papers

Mechanisms of ribosome rescue in bacteria

Kenneth C. Keiler, 2015, Nature Reviews Microbiology on p. 285-297

Kenneth C. Keiler, Heather A. Feaga, 2014, Journal of Bacteriology on p. 2123-2130

Nicholas A. Dillon, Nicholas D. Peterson, Heather A. Feaga, Kenneth C. Keiler, Anthony D. Baughn, 2017, Scientific Reports on p. 6135

Andrew W. Simonson, Andrew Simonson^, Atip Lawanprasert, Atip Lawanprasert^, Tyler D.P. Goralski, Kenneth C. Keiler, Scott Medina*, 2019, Nanomedicine: Nanotechnology, Biology, and Medicine on p. 391-400

Heather A. Feaga, Patrick H. Viollier, Kenneth C. Keiler, 2014, mBio

Heather A. Feaga, Michael D. Quickel, Pamela A. Hankey-Giblin, Kenneth C. Keiler, 2016, PLoS Genetics

John N. Alumasa, Paolo S. Manzanillo, Nicholas D. Peterson, Tricia Lundrigan, Anthony D. Baughn, Jeffery S. Cox, Kenneth C. Keiler, 2017, ACS Infectious Diseases on p. 634-644

Christoph H.R. Senges, Jennifer J. Stepanek, Michaela Wenzel, Nadja Raatschen, Ümran Ay, Yvonne Märtens, Pascal Prochnow, Melissa Vázquez Hernández, Abdulkadir Yayci, Britta Schubert, Niklas B.M. Janzing, Helen L. Warmuth, Martin Kozik, Jens Bongard, John N. Alumasa, Bauke Albada, Maya Penkova, Tadeja Lukežič, Nohemy A. Sorto, Nicole Lorenz, Reece G. Miller, Bingyao Zhu, Martin Benda, Jörg Stülke, Sina Schäkermann, Lars I. Leichert, Kathi Scheinpflug, Heike Brötz-Oesterhelt, Christian Hertweck, Jared T. Shaw, Hrvoje Petković, Jean M. Brunel, Kenneth C. Keiler, Nils Metzler-Nolte, Julia E. Bandow, 2021, Antimicrobial Agents and Chemotherapy

Shaima A. El-Mowafi, John N. Alumasa, Sarah E. Ades, Kenneth C. Keiler, 2014, Antimicrobial Agents and Chemotherapy on p. 5500-5509

Tyler D.P. Goralski, Girish S. Kirimanjeswara, Kenneth C. Keiler, 2018, mBio

News Articles Featuring Kenneth Keiler

Lab Bench to Commercialization 2024 grant recipients announced

Four projects led by researchers in the Penn State Eberly College of Science have been selected to receive Lab Bench to Commercialization (LB2C) grants in 2024

Penn State announces 2023 University-wide faculty and staff awards

Each spring, Penn State recognizes outstanding faculty and staff with annual awards in teaching and excellence. These awards highlight many of the University's faculty and staff who go above and beyond in their work at Penn State.

Keiler honored with 2023 Graduate Program Chair Leadership Award

Kenneth Keiler, professor of biochemistry and molecular biology and associate department head for graduate education in Penn State's Eberly College of Science, is the 2023 recipient of the Graduate School Alumni Society Graduate Program Chair Leadership Award.

Why COVID-19 Made This Sexually Transmitted Superbug Even Worse

COVID-19 has rightfully dominated infectious disease news since 2020. However, that doesn’t mean other infectious diseases took a break. In fact, U.S. rates of infection by gonorrhea have risen during the pandemic.

Gonorrhea became more drug resistant while attention was on COVID-19 – a molecular biologist explains the sexually transmitted superbug

COVID-19 has rightfully dominated infectious disease news since 2020. However, that doesn’t mean other infectious diseases took a break. In fact, U.S. rates of infection by gonorrhea have risen during the pandemic.

New antibiotic clears multi-drug resistant gonorrhea in mice in single dose

A new antibiotic compound clears infection of multi-drug resistant gonorrhea in mice in a single oral dose, according to a new study led by researchers at Penn State and Emory University.

Developing a novel oral antibiotic to treat multidrug-resistant gonorrhea

Up to $2.86M has been awarded to a research team including Penn State scientists to develop a new oral antibiotic to treat multidrug-resistant gonorrhea, a sexually transmitted disease caused by bacteria that have developed resistance to all but one existing antibiotic.